Tumor-infiltrating T cells may be markers to predict patients' responses to cancer immunotherapy
New insights into a population of tumor-infiltrating T cells may ultimately allow doctors to predict how patients will respond to checkpoint blockade immunotherapy, a form of cancer treatment with advantages that doctors ...